Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-342,181
Closed -$21.2M 80
2018
Q3
$21.2M Buy
342,181
+6,913
+2% +$394K 1.81% 25
2018
Q2
$17.7M Buy
335,268
+773
+0.2% +$41.8K 1.64% 27
2018
Q1
$18.4M Buy
334,495
+3,085
+0.9% +$190K 1.7% 28
2017
Q4
$22.6M Sell
331,410
-6,572
-2% -$443K 2.05% 26
2017
Q3
$24.2M Sell
337,982
-5,201
-2% -$362K 2.25% 25
2017
Q2
$23.3M Sell
343,183
-3,628
-1% -$247K 2.21% 23
2017
Q1
$23.4M Sell
346,811
-918
-0.3% -$61.2K 2.26% 23
2016
Q4
$21.5M Buy
347,729
+71
+0% +$4.2K 2.09% 24
2016
Q3
$18.8M Buy
347,658
+1,315
+0.4% +$66.3K 1.89% 26
2016
Q2
$15.8M Buy
+346,343
New +$16.9M 1.63% 27

Other funds holding ENOV

Summitry LLC's ENOV Position: Q4 2018 in Review

Summitry LLC sold out of Enovis (ENOV) in Q4 2018, closing a stake of 342,181 shares — an estimated $21.2M sold.

Summitry LLC first reported a position in ENOV in Q2 2016 and held it in 10 quarters. The position peaked at $24.2M in Q3 2017. 213 funds tracked by Wall St. Rank hold ENOV as of Q4 2018.

  • Summitry LLC reported no remaining Enovis position as of Q4 2018 after selling out during the quarter.
  • Summitry LLC sold 342,181 Enovis shares in Q4 2018, an estimated $21.2M.
  • Summitry LLC first reported a position in Enovis in Q2 2016 and held it in 10 quarters.
  • Summitry LLC's Enovis position peaked at $24.2M in Q3 2017.
  • 213 funds tracked by Wall St. Rank held Enovis as of Q4 2018.

Based on Summitry LLC's 13F filing for Q4 2018, filed 8 Feb 2019.